AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,900.00p
   
  • Change Today:
      66.00p
  • 52 Week High: 12,940.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.71m
  • Volume: 3,180,951
  • Market Cap: £200,042m
  • RiskGrade: 123
  • Beta: 1.32

Latest ShareCast News

AstraZeneca beats Q3 expectations, maintains FY outlook

By Iain Gilbert

Date: Thursday 06 Nov 2025

(Sharecast News) - Drugmaker AstraZeneca reiterated its full-year guidance on Thursday as it posted a third-quarter earnings beat, driven by solid sales of its cancer, heart and kidney disease drugs.

AstraZeneca's Koselugo receives EU approval

By Iain Gilbert

Date: Tuesday 28 Oct 2025

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo asset has been approved for usage in the European Union for the rare, progressive, genetic condition, plexiform neurofibromas, in adults with neurofibromatosis type 1.

Astrazeneca's Tezspire secures EU approval

By Iain Gilbert

Date: Wednesday 22 Oct 2025

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its chronic rhinosinusitis with nasal polyps treatment, Tezspire, has been approved in the European Union as an add-on therapy with intranasal corticosteroids for adults.

AstraZeneca lupus treatment gets EU approval 20-Oct-2025 ShareCast
Deutsche Bank downgrades AstraZeneca to 'sell' 16-Oct-2025 ShareCast
AstraZeneca to cut US drug prices in key White H... 13-Oct-2025 ShareCast
AstraZeneca's Baxdrostat hits Phase III endpoint... 07-Oct-2025 ShareCast
London midday: Stocks mixed with French and US f... 06-Oct-2025 ShareCast
London midday: UK stocks keep grinding towards y... 03-Oct-2025 ShareCast
Trump's MFN deal with Pfizer could be bellwether... 01-Oct-2025 ShareCast
AstraZeneca to list in New York, retain London l... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast
EU approves AstraZeneca's Tezspire to treat nasa... 22-Sep-2025 ShareCast
London close: Stocks mixed ahead of central bank... 15-Sep-2025 ShareCast
AstraZeneca to pause £200m Cambridge investment,... 15-Sep-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on corporate updates,... 29-Jul-2025 ShareCast
Astrazeneca H1 gross profits up 10pc as 'strong ... 29-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
AstraZeneca reports positive results from autoim... 24-Jul-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,900.00p
Change Today 66.00p
% Change 0.51 %
52 Week High 12,940.00p
52 Week Low 9,667.00p
Volume 3,180,951
Shares Issued 1,550.71m
Market Cap £200,042m
Beta 1.32
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 07-Nov-2025

Time Volume / Share Price
14:53 0 @ 12,874.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page